Molecular mechanisms of Down syndrome

Authors

Keywords:

síndrome de Down, embriología, cromosoma 21, desarrollo embrionario, diagnóstico prenatal

Abstract

Down syndrome is a genetic condition characterized by the presence of an extra copy of chromosome 21. The embryology of Down syndrome has been the subject of intense research to understand how this chromosomal alteration affects embryonic and fetal development. During the early stages of gestation, alterations are observed in cell migration, proliferation, and tissue differentiation, which may influence the physical and neurological characteristics typical of the syndrome. The main objective of this article is to examine the embryological aspects of Down syndrome, focusing on the mechanisms of nondisjunction and their impact on embryonic development to provide a deeper understanding of how chromosomal abnormalities emerge and affect prenatal development. Through an exhaustive literature search using PubMed and Google Scholar, studies published in the last five years (2019-2024) were included to ensure the inclusion of up-to-date research. The findings of the selected studies were synthesized to provide a comprehensive overview of current knowledge on DS from an embryological perspective. Advances in genetics and molecular biology have made it possible to identify the mechanisms underlying these disorders. These findings offer new opportunities to improve prenatal diagnosis and early management of the condition, with a focus on early intervention.

Downloads

Download data is not yet available.

References

Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, et al. Down syndrome. Nat Rev Dis Primers [Internet]. 2020 [citado 11/09/2024];6(1):9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428796/

Koul AM, Ahmad F, Bhat A, Aein Q ul, Ahmad A, Reshi AA, et al. Unraveling Down Syndrome: From Genetic Anomaly to Artificial Intelligence-Enhanced Diagnosis. Biomedicines [Internet]. 2023 [citado 11/09/2024];11(12):3284. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10741860/

Bianchi DW, Simpson JL, McGillivray B. Genetic Disorders and the Child: A Guide to Diagnosis and Management. 6ta ed Luxemburgo:Springer; 2014.

Akhtar F, Bokhari SRA. Down Syndrome. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [citado 12/09/2024]. Disponible en:

https://www.ncbi.nlm.nih.gov/books/NBK526016/

Baburamani AA, Patkee PA, Arichi T, Rutherford MA. New approaches to studying early brain development in Down syndrome. Dev Med Child Neurol. 2019 [citado 12/09/2024];61(8):867-79.

Windsperger K, Hoehl S. Development of Down Syndrome Research Over the Last Decades–What Healthcare and Education Professionals Need to Know. Front Psychiatry. 2021 [citado 12/09/2024];12:749046. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712441/

Rondal JA. From the lab to the people: major challenges in the biological treatment of Down syndrome. AIMS Neurosci . 2021 [citado 12 /09/ 2024]; 8(2):284-94. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940110/

Ishihara K. Genes Associated with Disturbed Cerebral Neurogenesis in the Embryonic Brain of Mouse Models of Down Syndrome. Genes (Basel). 2021 [citado 12 /09/ 2024];12(10):1598. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535956/

PLAIASU V. Down Syndrome – Genetics and Cardiogenetics. Maedica (Bucur). 2017 [citado 12/09/2024];12(3):208-13. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706761/

Gottlieb SF, Tupper C, Kerndt CC, Tegay DH. Genetics, Nondisjunction. En: StatPearls Treasure Island (FL): StatPearls Publishing; 2024 [citado 12/09/2024]. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK482240/

Blanco-Montaño A, Ramos-Arenas M, Yerena-Echevarría BA, Miranda-Santizo LD, Ríos-Celis AL, Dorantes-Gómez AT, et al. Factores de riesgo en el origen del síndrome de Down. Rev Med Inst Mex Seguro Soc. 2023 [citado 12/09/2024];61(5):638-44. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599770/

Rafii MS, Kleschevnikov AM, Sawa M, Mobley WC. Down syndrome. Handb Clin Neurol. 2019;167:321- 36.

Halevy T, Biancotti JC, Yanuka O, Golan-Lev T, Benvenisty N. Molecular Characterization of Down Syndrome Embryonic Stem Cells Reveals a Role for RUNX1 in Neural Differentiation. Stem Cell Reports. 2016 [citado 12/09/2024];7(4):777-86. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063584/

Klein JA, Haydar TF. Neurodevelopment in Down syndrome: Concordance in humans and models. Front Cell Neurosci. 2022 [citado 12/09/2024];16:941855. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334873/

Dimopoulos K, Constantine A, Clift P, Condliffe R, Moledina S, Jansen K, et al. Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus. Circulation. 2023 [citado 12/09/2024];147(5):425-41. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977420/

Sanaa B, Abdenasser D, Ayoub EH. Congenital heart disease and Down syndrome: various aspects of a confirmed association. Cardiovasc J Afr. 2016 [citado12/09/2024];27(5):287-90. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370349/

Asim A, Kumar A, Muthuswamy S, Jain S, Agarwal S. “Down syndrome: an insight of the disease”. J Biomed Sci. 2015 [citado 12/09/2024];22(1):41. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464633/

CILHOROZ BT, RECENO CN, HEFFERNAN KS, DERUISSEAU LR. Cardiovascular Physiology and Pathophysiology in Down Syndrome. Physiol Res. 2022 [citado12/09/2024];71(1):1-16. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997681/

Tarui T, Im K, Madan N, Madankumar R, Skotko BG, Schwartz A, et al. Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome. Cereb Cortex. 2020 [citado 12/09/2024];10;30(1):382-390. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7029684/pdf/bhz094.pdf

Patkee PA, Baburamani AA, Kyriakopoulou V, Davidson A, Avini E, Dimitrova R, et al. Early alterations in cortical and cerebellar regional brain growth in Down Syndrome: An in vivo fetal and neonatal MRI assessment. Neuroimage Clin. 2019 [citado 12 /09/2024];25:102139. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938981/

Published

2025-11-13

How to Cite

1.
Valdivieso Solorzano ZS, Aldas Acosta DM, Padilla Barragán DE. Molecular mechanisms of Down syndrome. CCM [Internet]. 2025 Nov. 13 [cited 2026 Feb. 14];29:e5416. Available from: https://revcocmed.sld.cu/index.php/cocmed/article/view/5416